AMBROXOL\CETIRIZINE: 63 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
63
Total FAERS Reports
0
Deaths Reported
51
Hospitalizations
63
As Primary/Secondary Suspect
Active Ingredient: AMBROXOL\CETIRIZINE HYDROCHLORIDE ·
First Report: 20180101 · Latest Report: 20180101
What Are the Most Common AMBROXOL\CETIRIZINE Side Effects?
#1 Most Reported
Drug ineffective
63 reports (100.0%)
#2 Most Reported
Macular degeneration
62 reports (98.4%)
#3 Most Reported
Weight decreased
49 reports (77.8%)
All AMBROXOL\CETIRIZINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 63 | 100.0% | 0 | 51 |
| Macular degeneration | 62 | 98.4% | 0 | 50 |
| Nausea | 49 | 77.8% | 0 | 47 |
| Paraesthesia oral | 49 | 77.8% | 0 | 47 |
| Pyrexia | 49 | 77.8% | 0 | 47 |
| Therapeutic product effect incomplete | 49 | 77.8% | 0 | 47 |
| Weight decreased | 49 | 77.8% | 0 | 47 |
| Chronic sinusitis | 48 | 76.2% | 0 | 46 |
| Dyspepsia | 48 | 76.2% | 0 | 46 |
| Infusion related reaction | 47 | 74.6% | 0 | 45 |
| Malaise | 47 | 74.6% | 0 | 45 |
| Off label use | 47 | 74.6% | 0 | 45 |
| Pain | 47 | 74.6% | 0 | 45 |
| Procedural pain | 47 | 74.6% | 0 | 45 |
| Abdominal pain | 39 | 61.9% | 0 | 39 |
| Anaemia | 39 | 61.9% | 0 | 39 |
| Colitis | 39 | 61.9% | 0 | 39 |
| Colitis ulcerative | 39 | 61.9% | 0 | 39 |
| Constipation | 39 | 61.9% | 0 | 39 |
| Erythema | 39 | 61.9% | 0 | 39 |
Who Reports AMBROXOL\CETIRIZINE Side Effects? Age & Gender Data
Gender: 100.0% female, 0.0% male. Average age: 70.0 years. Most reports from: CA. View detailed demographics →
Is AMBROXOL\CETIRIZINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2018 | 9 | 0 | 9 |
What Is AMBROXOL\CETIRIZINE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 58 |
Official FDA Label for AMBROXOL\CETIRIZINE
Official prescribing information from the FDA-approved drug label.